Jeannie Joughin, PhD, is a Consultant to Enable Injections. Previously she was Vice-President of Corporate Development at the company and was responsible for business development, strategic alliances, alliance management, marketing and clinical activities. Prior to Enable she held various scientific positions including Senior Research Scientist, Post-Doctorate and Senior Post-Doctorate positions in Australia at The Alfred Hospital, The Walter & Eliza Hall Institute, as well as internationally in Austria (University Clinic, Innsbruck) and Switzerland (Ludwig Institute for Cancer Research, Lausanne).
Dr Joughin began her career in the pharmaceutical industry in 1992 as a Clinical Research Manager with Bristol-Myers Squibb. After successfully completing several marketing roles in the National Stroke Foundation, MediMark International and Mayne Pharma, Dr Joughin joined CSL Biotherapies in 2005 as Director, Pharmaceuticals Marketing and In-licensing. She assumed responsibility for a portfolio of pharmaceutical products from several licensing partners in various therapeutic areas. As Vice-President, Business Development at CSL Behring, Joughin was responsible for managing business licensing arrangements and relationships. This involved close liaison with CSL Behring’s Commercial Development Team in the US, Germany and Switzerland.